Skip to main content
. 2019 Nov 22;31(3):533–545. doi: 10.1007/s00198-019-05228-8

Fig. 3.

Fig. 3

Kaplan–Meier analysis of discontinuation with each medication class over a 5-year period in the “‘Drug-specific’ Specific” cohort, using a 30-day permissible gap. Patients could contribute multiple records. The numbers at risk for each medication represent the number of records not the number of patients. PTH parathyroid hormone, SERM selective estrogen receptor modulators